跳至主要内容
临床试验/NCT04405869
NCT04405869Unknown不适用

Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年4月29日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
Analysis of incidence of thromboembolic events in patients with Sars-CoV-2

研究概览

简要总结

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed infection with the Sars-CoV-2 virus (RT-PCR)
  • Hospitalization in Intensive Care Unit
  • Age over 18 years Old

排除标准

  • Refusal of the patient to participate in data collection

结局指标

主要结局

Analysis of incidence of thromboembolic events in patients with Sars-CoV-2

时间窗: 1 month

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Thromboembolic Events in Severe COVID-19 Patients | 临床试验